Lansforsakringar Fondforvaltning AB publ Acquires 13,600 Shares of Cardinal Health, Inc. $CAH

Lansforsakringar Fondforvaltning AB publ boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 17.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 90,232 shares of the company’s stock after purchasing an additional 13,600 shares during the quarter. Lansforsakringar Fondforvaltning AB publ’s holdings in Cardinal Health were worth $19,067,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of CAH. Aventura Private Wealth LLC bought a new position in shares of Cardinal Health in the fourth quarter valued at about $25,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Cardinal Health during the 4th quarter worth about $26,000. Bank of Jackson Hole Trust acquired a new position in Cardinal Health in the 4th quarter valued at about $27,000. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares during the last quarter. Finally, Palladiem LLC bought a new position in Cardinal Health in the 4th quarter valued at about $28,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.7%

Shares of Cardinal Health stock opened at $237.87 on Wednesday. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $240.93. The company has a market capitalization of $55.71 billion, a price-to-earnings ratio of 36.37, a PEG ratio of 1.29 and a beta of 0.52. The firm’s 50-day moving average price is $207.00 and its two-hundred day moving average price is $210.93.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts expect that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Wednesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s dividend payout ratio is currently 31.50%.

Wall Street Analyst Weigh In

CAH has been the subject of several research reports. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Monday, June 15th. Robert W. Baird set a $248.00 target price on Cardinal Health in a research note on Friday, May 1st. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a report on Tuesday, May 19th. JPMorgan Chase & Co. reduced their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a research note on Monday, May 4th. Finally, Zacks Research downgraded Cardinal Health from a “strong-buy” rating to a “hold” rating in a research note on Friday, June 12th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $246.93.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.